Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation24-08-2024
24-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Un-Audited Financial Results For The Quarter Ended 30.06.2024
Un-Audited Financial Results for the quarter ended 30.06.202424-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting24-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to requirement of Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, this is to inform you that Akums Drugs & Pharmaceuticals Limited will be hosting earnings/analysts conference call on Friday, August 30, 2024 at 4:00 PM IST for limited reviewed un-audited financial results of Q1 FY25.23-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Commencement Of Commercial Production Of Second Production Facility By Wholly Owned Subsidiary Company - Akums Healthcare Limited Of The Company
Commencement of Commercial Production of second production facility by wholly owned subsidiary company - Akums Healthcare Limited, of the company.22-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Board Meeting Intimation for Considering And Approving The Un-Audited (Standalone & Consolidated) Financial Results For The Quarter Ended 30Th June, 2024.
Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2024 ,inter alia, to consider and approve the Un-audited (Standalone & Consolidated) Financial Results for the quarter ended 30th June, 2024.21-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Clarification On Price Movement
Clarification on Price Movement20-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Clarification sought from Akums Drugs and Pharmaceuticals Ltd
The Exchange has sought clarification from Akums Drugs and Pharmaceuticals Ltd on August 19, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.20-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information
Code of Practice and Procedure for fair disclosure of Unpublished Price Sensitive Information07-08-2024